People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

Heat sensitivity makes July 4 columnist Leigh Anne Nelson's least favorite holiday. This year, she'll be listening to her ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...